Related content

Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups

By Scott Stuart A   Khasawneh Rame   Peter Inga   Kornreich Ruth   Desnick Robert J  

Pharmacogenomics, Vol. 11, Iss. 6, 2010-06 ,pp. : 781-791

Future Medicine

Access to resources Recommend Favorite

VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study

By Zambon Carlo-Federico   Pengo Vittorio   Padrini Roberto   Basso Daniela   Schiavon Stefania   Fogar Paola   Nisi Alessandra   Frigo Anna Chiara   Moz Stefania   Pelloso Michela   Plebani Mario  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 15-25

Future Medicine

Access to resources Recommend Favorite

Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU

By Scott Stuart A   Patel Manishkumar   Martis Suparna   Lubitz Steven A   van der Zee Sarina   Yoo Chang   Edelmann Lisa   Halperin Jonathan L   Desnick Robert J  

Pharmacogenomics, Vol. 13, Iss. 3, 2012-02 ,pp. : 297-307

Future Medicine

Access to resources Recommend Favorite

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European––Americans and African––Americans

By Limdi Nita A   Arnett Donna K   Goldstein Joyce A   Beasley T Mark   McGwin Gerald   Adler Brian K   Acton Ronald T  

Pharmacogenomics, Vol. 9, Iss. 5, 2008-05 ,pp. : 511-526

Future Medicine

Access to resources Recommend Favorite

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity

By Dandara Collet   Lombard Zané   Du Plooy Ingrid   McLellan Tracy   Norris Shane A   Ramsay Michèle  

Pharmacogenomics, Vol. 12, Iss. 12, 2011-12 ,pp. : 1663-1670

Future Medicine

Access to resources Recommend Favorite